Treatments for methamphetamine abuse: a literature review for the clinician (Q34233794)

31 July 2017

title

Treatments for methamphetamine abuse: a literature review for the clinician (English)

1 reference

31 July 2017

1 reference

Todd Brackins

1

1 reference

31 July 2017

Nancy C Brahm

series ordinal

2

1 reference

31 July 2017

Julie C Kissack

series ordinal

3

1 reference

31 July 2017

publication date

17 November 2011

1 reference

Journal of Pharmacy Practice

31 July 2017

published in

1 reference

31 July 2017

volume

24

1 reference

31 July 2017

issue

6

1 reference

31 July 2017

page(s)

541-550

1 reference

Methamphetamine use is associated with increased hospital resource consumption among minimally injured trauma patients

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0897190011426557

Cocaine and other stimulants. Actions, abuse, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011426557

Monoamine transporter as a target molecule for psychostimulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011426557

The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011426557

Methamphetamine induces long-term alterations in reactivity to environmental stimuli: correlation with dopaminergic and serotonergic toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011426557

Methamphetamine preconditioning alters midbrain transcriptional responses to methamphetamine-induced injury in the rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011426557

An exploratory study: the use of paroxetine for methamphetamine craving

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011426557

Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011426557

Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011426557

Bupropion for the treatment of methamphetamine dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011426557

Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011426557

A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011426557

Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: a comparison of mirtazapine and modafinil with treatment as usual

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011426557

Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011426557

A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011426557

Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011426557

A randomized, placebo-controlled trial of sustained-release dextroamphetamine for treatment of methamphetamine addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011426557

A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011426557

An open-label pilot study of risperidone in the treatment of methamphetamine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011426557

Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of D-amphetamine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011426557

Aripiprazole as a potential pharmacotherapy for stimulant dependence: human laboratory studies with d-amphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011426557

A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011426557

Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011426557

Randomized, placebo-controlled trial of baclofen and gabapentin for the treatment of methamphetamine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011426557

21 January 2018

Identifiers

DOI

10.1177/0897190011426557

1 reference

release_jpoauij7fvfkbeulbva3dvroj4

31 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jpoauij7fvfkbeulbva3dvroj4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference